Rtw Investments, LP Iveric Bio, Inc. Transaction History

Rtw Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $48.3 Million - $67.1 Million	-2,803,712 Reduced 77.34%	821,288 $17.6 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $34.1 Million - $67.4 Million	3,625,000 New	3,625,000 $65 Million
Q1 2022 May 16, 2022	SELL	$12.15 - $16.83 $81.7 Million - $113 Million	-6,722,624 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.65 - $7.66 $334,395 - $453,357	59,185 Added 0.89%	6,722,624 $46.5 Million
Q3 2020 Nov 16, 2020	BUY	$4.01 - $6.29 $268,281 - $420,819	66,903 Added 1.01%	6,663,439 $37.6 Million

Q2 2020 Aug 14, 2020	BUY	$3.06 - $6.6 $20.2 Million - $43.5 Million	6,596,536 New	6,596,536 $33.6 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.